Eight kit options provide full-length, paired receptor chain data for human, mouse, or hybrid samples, without the need for specialized instruments or expensive reagents. MOUNTAIN VIEW — Cellecta, Inc., a leader in functional genomics and immune profiling technologies, today announced the launch of its new DriverMap™ Single-Cell Adaptive Immune Receptor (scAIR) TCR-BCR assay product line, […]
Following regulatory approval, Advanced Instruments, a wholly-owned subsidiary within Patricia Industries, has now completed its acquisition of Nova Biomedical, a global provider of analytical instruments and consumables for the biopharmaceutical and clinical markets. The enterprise value amounts to USD 2.2bn. Patricia Industries has contributed USD 1.6bn in financing. The remainder of the enterprise value has […]
Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Männedorf, Switzerland – The Tecan Group (SIX Swiss Exchange: TECN) today announced a planned CEO transition, marking a new chapter in the company’s successful growth story. After nearly 12 years with Tecan, including 6 ½ years as CEO, Dr. Achim von […]
Integration of firefly® liquid handling platform and SemaCyte® microcarriers enables flexible, miniaturized, and automated cell assay workflows Cambridge, UK: SPT Labtech, a global leader in innovative laboratory automation, today announced a strategic collaboration with Semarion, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell biology to tackle unmet drug […]
The MAVEN® Real Time Glucose Control Platform from Repligen will be used to perform real-time monitoring of glucose and lactate in the range of scale-X™ bioreactors for adherent cell culture processes. Nivelles, Belgium – Univercells Technologies, a Donaldson Life Sciences business and global provider of bioprocessing solutions, announced a collaboration with Repligen Corporation to integrate real-time monitoring capabilities and […]
We awarded the 2025 Future Insight Prize – a 250.000 € research grant – to Prof. Magdalena Götz, Munich, Germany today. Darmstadt, Germany — Merck KGaA, Darmstadt, Germany, a leading science and technology company, today awarded the 2025 Future Insight Prize to Prof. Magdalena Götz, representing the Helmholtz Center Munich. The award – a € 250,000 research […]
Company empowers ADME, hepatobiology, and toxicity research toward the goal of reducing the risk of adverse drug effects BALTIMORE — BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, today announced the opening of its Hepatocyte Grants Program and that it is actively reviewing research proposals. As a leader in […]
BILLERICA, Mass. — Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced that it has completed its previously announced acquisition of Akoya Biosciences, Inc., establishing a scaled leader in the early detection of disease for the neurology, oncology and immunology markets. Under the terms of […]
Researchers aim to discover dominant subtypes of plasmablasts initiating from the MMR vaccine in order to develop neutralizing antibody candidate therapies SEATTLE, Wash. — The Vanderbilt University Medical Center and Parse Biosciences today announced a strategic collaboration to generate a single cell atlas focused on understanding the diversity of plasmablasts – early immune cell clonotypes critical […]
Hamburg — This year, the Hamburg based life sicences company Eppendorf SE is awarding its prestigious research prize for the 30th time. The independent jury chaired by Prof. Laura Machesky, Cambridge, UK, selected Dr. Varun Venkataramani, Heidelberg University Hospital, Germany as the winner of the Eppendorf Award for Young European Investigators 2025. Varun Venkataramani receives the […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
